These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3014927)

  • 41. Ontogeny of host responses in ovine fetuses infected with bluetongue virus.
    Enright FM; Osburn BI
    Am J Vet Res; 1980 Feb; 41(2):224-9. PubMed ID: 6245604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laboratory tests for evaluating the level of attenuation of bluetongue virus.
    Franchi P; Mercante MT; Ronchi GF; Armillotta G; Ulisse S; Molini U; Di Ventura M; Lelli R; Savini G; Pini A
    J Virol Methods; 2008 Nov; 153(2):263-5. PubMed ID: 18706450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of genome segments 2, 7 and 10 of bluetongue viruses serotype 2 for differentiation between field isolates and the vaccine strain.
    Bréard E; Sailleau C; Coupier H; Mure-Ravaud K; Hammoumi S; Gicquel B; Hamblin C; Dubourget P; Zientara S
    Vet Res; 2003; 34(6):777-89. PubMed ID: 14746772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contagious ecthyma virus-vaccination failures.
    Buddle BM; Dellers RW; Schurig GG
    Am J Vet Res; 1984 Feb; 45(2):263-6. PubMed ID: 6711950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [What BTV-8 can do, any other serotype can do, too].
    Haneveld JK
    Tijdschr Diergeneeskd; 2008 Oct; 133(20):856-8. PubMed ID: 18975627
    [No Abstract]   [Full Text] [Related]  

  • 46. Experimental reproduction of bluetongue virus serotype 8 clinical disease in calves.
    Dal Pozzo F; De Clercq K; Guyot H; Vandemeulebroucke E; Sarradin P; Vandenbussche F; Thiry E; Saegerman C
    Vet Microbiol; 2009 May; 136(3-4):352-8. PubMed ID: 19128895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants.
    Perrin A; Albina E; Bréard E; Sailleau C; Promé S; Grillet C; Kwiatek O; Russo P; Thiéry R; Zientara S; Cêtre-Sossah C
    Vaccine; 2007 Sep; 25(37-38):6774-83. PubMed ID: 17669563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bluetongue: characterization of virus types by reverse transcription-polymerase chain reaction.
    Zientara S; Bréard E; Sailleau C
    Dev Biol (Basel); 2006; 126():187-96; discussion 326-7. PubMed ID: 17058494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of endothelial cell-derived inflammatory and vasoactive mediators in the pathogenesis of bluetongue.
    DeMaula CD; Leutenegger CM; Bonneau KR; MacLachlan NJ
    Virology; 2002 May; 296(2):330-7. PubMed ID: 12069531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A lot of interest in blue tongue vaccination].
    Haneveld JK
    Tijdschr Diergeneeskd; 2008 Jul 15-Aug 1; 133(14-15):622-3. PubMed ID: 18767305
    [No Abstract]   [Full Text] [Related]  

  • 51. Differentiation of Italian field and South African vaccine strains of bluetongue virus serotype 2 using real-time PCR.
    Orrù G; Santis PD; Solinas F; Savini G; Piras V; Caporale V
    J Virol Methods; 2004 Dec; 122(1):37-43. PubMed ID: 15488618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bluetongue virus: virology, pathogenesis and immunity.
    Schwartz-Cornil I; Mertens PP; Contreras V; Hemati B; Pascale F; Bréard E; Mellor PS; MacLachlan NJ; Zientara S
    Vet Res; 2008; 39(5):46. PubMed ID: 18495078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep.
    Luján L; Pérez M; Salazar E; Álvarez N; Gimeno M; Pinczowski P; Irusta S; Santamaría J; Insausti N; Cortés Y; Figueras L; Cuartielles I; Vila M; Fantova E; Chapullé JL
    Immunol Res; 2013 Jul; 56(2-3):317-24. PubMed ID: 23579772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of viral infection on nervous system development. II. Attempts to modify bluetongue-virus-induced malformations with cyclophosphamide and antithymocyte serum.
    Narayan O; McFarland HF; Johnson RT
    Am J Pathol; 1972 Jul; 68(1):15-22. PubMed ID: 4342991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. WHO/FAO Working Team Report: immunology.
    Osburn BI; Calisher CH; Jochim MM; Campbell CH; Littlejohns I; Carbrey EA; Pearson JE; Della-Porta AJ; Shope RE; Erasmus BJ
    Prog Clin Biol Res; 1985; 178():697-8. PubMed ID: 2989921
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of viral infection on nervous system development. I. Pathogenesis of bluetongue virus infection in mice.
    Narayan O; Johnson RT
    Am J Pathol; 1972 Jul; 68(1):1-14. PubMed ID: 4342993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccination against bluetongue.
    Vet Rec; 2012 Jan; 170(1):16. PubMed ID: 22228865
    [No Abstract]   [Full Text] [Related]  

  • 58. Cutaneous lymphoid traffic in sheep infected with bluetongue virus.
    Ellis JA; Luedke AJ; Nunamaker CE; Nunamaker RA; Haven TR
    Vet Pathol; 1991 Mar; 28(2):175-8. PubMed ID: 1648279
    [No Abstract]   [Full Text] [Related]  

  • 59. Sheep pox: experimental studies with a west african isolate.
    Afshar A; Bundza A; Myers DJ; Dulac GC; Thomas FC
    Can Vet J; 1986 Aug; 27(8):301-6. PubMed ID: 17422683
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bluetongue vaccination roadshows.
    Anderson I
    Vet Rec; 2008 Apr; 162(14):459. PubMed ID: 18390861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.